Atlas Trials

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT04788745 · COMPLETED

Trial details

NCT number
NCT04788745
Sponsor
The University of Queensland
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Amyotrophic Lateral SclerosisMotor Neuron Disease
Start date
2021-06-29
Primary completion
2023-05-24
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.